A phase I/II clinical trial found that the most common side effects were mild and transient (Teichman et al., 2006): Injection site reactions (redness, mild swelling) Headaches Flushing or warmth Temporary water retention Joint tightness or tingling Transient fatigue or dizziness Serious adverse events are rare when the peptide is used under medical supervision at appropriate doses
Locomotor activity and stereotypic behaviors, immobility duration (forced swim test), and increased transfer latency (elevated plus maze) were performed to test the effect of hesperidin (50 mg/kg, 100 mg/kg, 200 mg/kg, p.o.) and coenzyme Q10 (20 mg/kg, 40 mg/kg, p.o.) and combination of hesperidin + coenzyme Q10 followed by biochemical and mitochondrial complexes assays
17(16):1612 to 1632
If I were to use this peptide, I would have straight away opted for stacking ipamorelin with some other peptide for quicker yet effective results
doi: 10.3389/fmolb.2025.1611842 Received 14 April 2025 Accepted 07 May 2025 Published 26 May 2025 Volume 12 - 2025 Edited by Claudia Fiorillo, University of Florence, Italy Reviewed by Larance Ronsard, Ragon Institute, United States Zekeriya Duzgun, Giresun University, Trkiye Updates Copyright 2025 Nuez-Selles, Nuez-Musa and Guillen-Marmolejos